Get started
Author

Signy Chow

Sensitive tumour detection and classification using plasma cell-free DNA methylomes
2018 · Shu Yi Shen, Rajat Singhania, et al. · Nature · 978
PDF
Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates
2017 · Olena Kis, Rayan Kaedbey, et al. · Nature Communications · 137
PDF
Proline residues in transmembrane segment IV are critical for activity, expression and targeting of the Na+/H+ exchanger isoform 1
2004 · Emily R. SLEPKOV, Signy CHOW, et al. · Biochemical Journal · 90
PDF
A link between hypercholesterolemia and chronic lymphocytic leukemia
2015 · Signy Chow, Rena Buckstein, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 33
Biomarker Driven Phase II Clinical Trial of Trametinib in Relapsed/Refractory Multiple Myeloma with Sequential Addition of the AKT Inhibitor, GSK2141795 at Time of Disease Progression to Overcome Treatment Failure: A Trial of the Princess Margaret Phase II Consortium
2016 · Suzanne Trudel, Nizar J. Bahlis, et al. · Blood · 20
Trimming the fat with an IVIG approval process
2012 · Signy Chow, Giselle Salmasi, et al. · Transfusion and Apheresis Science · 16
Myeloma immunoglobulin rearrangement and translocation detection through targeted capture sequencing
2022 · Signy Chow, Olena Kis, et al. · Life Science Alliance · 15
PDF
Predictors of unsuccessful mobilization with granulocyte colony‐stimulating factor alone in patients undergoing autologous hematopoietic stem cell transplantation
2013 · Signy Chow, Alejandro Lazo‐Langner, et al. · Journal of Clinical Apheresis · 11
Breakthrough Invasive Fungal Infection After Coadministration of Venetoclax and Voriconazole
2023 · Victoria G Hall, Kenny Tang, et al. · Open Forum Infectious Diseases · 10
RUNX1 mutations correlate with response to venetoclax combination therapies in relapsed/refractory acute myeloid leukemia
2021 · Signy Chow, Kenny Tang, et al. · Leukemia Research · 10
Report of Consensus Panel 1 from the 12th International Workshop on the management of patients with IgM and Waldenstrom's Macroglobulinemia related neuropathy
2025 · Shirley D'Sa, Jahanzaib Khwaja, et al. · Seminars in Hematology · 9
Posterior reversible encephalopathy syndrome in a patient with multiple myeloma treated with thalidomide
2011 · Signy Chow, Christina S. Cheung, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 8
Report of Consensus Panel 3 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with high-risk disease
2025 · Prashant Kapoor, Meletios A. Dimopoulos, et al. · Seminars in Hematology · 7
Incorporating biobanking into the future of healthcare: exploring patient and healthcare worker perspectives at a Canadian tertiary academic hospital
2025 · Sila Usta, Noor Kundu, et al. · European Journal of Human Genetics · 5
PDF
CPX351 Has Short Remission Duration but Is an Effective Bridge to Allogeneic Transplant in High Risk AML: Results from Canadian Real-World Multi-Centre Study
2020 · Claire Andrews, Taylor Young, et al. · Blood · 5
Mixed fields on RhD typing as an indication of loss of heterozygosity on chromosome 1p in acute myeloid leukemia
2014 · Signy Chow, Jacob Pendergrast, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 3
Aberrant splicing of MBD1 reshapes the epigenome to drive convergent myeloerythroid defects in MDS
2026 · He Tian Tony Chen, Pratik Joshi, et al. · Blood · 2
Diagnosis of systemic mastocytosis with cryptic deletion of TET2 and DNMT3A resulting from unbalanced translocation
2024 · Signy Chow, Stephanie Lee, et al. · British Journal of Haematology · 2
Targeted Capture and Sequencing of Immunoglobulin Rearrangements in Multiple Myeloma to Enable Detection of Minimal Residual Disease
2017 · Signy Chow · TSpace (University of Toronto) · 2
PDF
Real‐world experience with CPX ‐351 for secondary acute myeloid leukaemia: Comparison with FLAG ‐ IDA in a propensity score matching analysis
2025 · Maria Agustina Perusini, Ana Flavia Patiño, et al. · British Journal of Haematology · 1
PDF
Cell-free DNA Whole Genome Sequencing for Non-Invasive Minimal Residual Disease Detection in Multiple Myeloma
2025 · Dor D. Abelman, Jenna Eagles, et al. · medRxiv · 1
Striving for excellence in paroxysmal nocturnal hemoglobinuria in Canada: the EPIC program
2025 · Hayeong Rho, Kelsey Yang, et al. · Journal of Rare Diseases · 1
PDF
Real-World Experience with CPX-351 for Secondary Acute Myeloid Leukemia: Comparison with FLAG-IDA in a Propensity Score Matching Analysis
2024 · Maria Agustina Perusini, Claire Andrews, et al. · Blood · 1
PDF
Integrating the Sunnybrook Biobank into the Future of Healthcare - Exploring Patient and Healthworker Biobanking Perspectives
2024 · Noor Kundu, Dylan Gowlett-Park, et al. · Blood · 1
PDF
Aberrant Splicing of MBD1 Reshapes the Epigenome to Drive Convergent Myeloerythroid Defects in MDS
2023 · He Tian (Tony) Tony Chen, Pratik Joshi, et al. · Blood · 1
PDF
Works count: 50
Citation count: 1,370
H-index: 10
I10-index: 10
Year
Topic
Type